Skip to main content

View full-text article in PMC

. 2018 Dec 20;43(3):1193–1202. doi: 10.3892/ijmm.2018.4037

Table II.

Effect of NBO on NIS.

Group	NIS at time points [median (IQR)]
Group	2 h	4 h	6 h	12 h	24 h	48 h
100% NBO	2.0 (1.75-3.0)	2.0 (1.0-2.5)	2.0 (1.75-2.25)	1.5 (1.0-3.0)	1.5 (1.0-2.0)^a	1.0 (1.0-2.0)^a
60% NBO	2.5 (1.75-3.0)	2.0 (1.75-3.0)	2.0 (1.75-3.0)	2.0 (1.0-2.25)	2.0 (1.0-2.0)^a	2.0 (1.0-2.0)^a
Control	2.0 (2.0-2.0)	2.0 (2.0-3.0)	2.0 (2.0-3.0)	2.5 (2.0-3.0)	3.0 (2.0-3.25)	3.0 (2.75-4.0)
H-value	1.195	1.123	0.821	2.698	8.833	11.152
P-value	0.550	0.570	0.663	0.260	0.012	0.004

The median (IQR) NIS for each group after NBO therapy, compared with the ischemic control group (n=6 per group). Data are expressed as median ± IQR.

^a

P<0.05 vs. the control group. NIS, neurologic impairment score; IQR, interquartile range; NBO, normobaric oxygen.